';
Tags Posts tagged with "Telehealth"

Telehealth

The Office of Developmental Programs (ODP) Technology Task Force is seeking input from providers about the use of Remote Supports, Assistive Technology, Teleservices, and Video Monitoring. The information collected will develop baseline data and inform future decisions related to supportive technology. We would like to thank all providers that have participated in the survey so far. We have extended the deadline so that all providers may have a chance to participate.

This brief survey should take approximately 5–10 minutes to complete. Please include information for all individuals served and for all service locations throughout your organization. Once collected, ODP plans to publish the results for all stakeholders.

The survey will close on Friday, May 5, 2023, at 4:00 pm.

Thank you for your participation.

To complete the survey, please use this link.

The Drug Enforcement Agency (DEA) is proposing to roll back flexibilities implemented during the public health emergency (PHE) in tele-prescribing buprenorphine. The proposed new regulation would mandate an initial in-person visit with a prescriber in order for a patient to receive more than a 30-day buprenorphine prescription. Since 2020, those with opioid use disorder have been able to receive prescriptions for buprenorphine, including the initial prescription, following a tele-appointment.

Patients who began buprenorphine treatment during the PHE under the expanded flexibilities would have a 180-day grace period but would then need to see a prescriber in person before continuing treatment under the DEA’s proposed rule.

The proposed rule and instructions for providing comments are available online. The public comment period closes March 31, 2023.